You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 19, 2025

Drug Price Trends for HM CHILD ALL DAY ALLER


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for HM CHILD ALL DAY ALLER

Average Pharmacy Cost for HM CHILD ALL DAY ALLER

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
HM CHILD ALL DAY ALLER 1 MG/ML 62011-0323-01 0.03411 ML 2025-02-19
HM CHILD ALL DAY ALLER 1 MG/ML 62011-0323-01 0.03376 ML 2025-01-22
HM CHILD ALL DAY ALLER 1 MG/ML 62011-0323-01 0.03190 ML 2024-12-18
HM CHILD ALL DAY ALLER 1 MG/ML 62011-0323-01 0.03194 ML 2024-11-20
HM CHILD ALL DAY ALLER 1 MG/ML 62011-0323-01 0.02849 ML 2024-10-23
HM CHILD ALL DAY ALLER 1 MG/ML 62011-0323-01 0.02764 ML 2024-09-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for HM CHILD ALL DAY ALLER (Cetirizine)

Overview of Cetirizine

Cetirizine, commonly known by brand names such as Zyrtec, is a selective histamine H1 receptor antagonist used to treat various allergic symptoms. It is effective in managing conditions like seasonal and perennial allergic rhinitis, and chronic idiopathic urticaria[1].

Market Size and Growth

The global allergy diagnostics and therapeutics market, which includes antihistamines like cetirizine, is experiencing significant growth. As of 2024, the market was valued at approximately $36.22 billion and is projected to reach around $66.60 billion by 2033, growing at a Compound Annual Growth Rate (CAGR) of 7%[3].

Regional Insights

In North America, which captures a substantial revenue share of the allergy diagnostics and therapeutics market, the segment is expected to reach around $18.33 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033. This region is a key market for antihistamines, including cetirizine[3].

Antihistamines Market Segment

The antihistamines drug class, which includes cetirizine, is poised for significant growth. This segment is expected to grow at a CAGR of 19% from 2024 to 2033, driven by increasing instances of allergies and the effectiveness of second-generation antihistamines like cetirizine in treating allergic symptoms without sedating effects[3].

Pricing and Availability

Over-the-Counter (OTC) Availability

Cetirizine is widely available as an OTC medication, which influences its pricing. OTC drugs are generally more affordable than prescription medications, making them accessible to a broader consumer base. For example, the Health Mart Children's All Day Allergy product, which contains cetirizine, is priced around $8.99, indicating a competitive and consumer-friendly pricing strategy[5].

Generic and Brand Name Pricing

The pricing of cetirizine can vary depending on whether it is a generic or brand-name product. Generic versions of cetirizine are typically cheaper than brand-name versions like Zyrtec. This competition from generic alternatives helps keep prices in check and makes the medication more affordable for consumers.

Price Projections

Given the growing demand for antihistamines and the expanding market size, here are some key points to consider for price projections:

Increasing Demand

  • The increasing prevalence of allergies, especially among children and adolescents, is driving the demand for effective antihistamines like cetirizine. This demand is likely to sustain the market growth and potentially stabilize or slightly increase prices due to higher production costs and market dynamics[3].

Competitive Market

  • The presence of multiple generic and brand-name options in the market keeps prices competitive. As more manufacturers enter the market, the competition is likely to maintain or reduce prices to attract consumers[1][5].

Regulatory and Economic Factors

  • Economic factors such as inflation, production costs, and regulatory changes can influence pricing. However, given the essential nature of antihistamines, regulatory bodies often ensure that these medications remain affordable for the general public.

Key Takeaways

  • Market Growth: The global allergy diagnostics and therapeutics market, including antihistamines like cetirizine, is expected to grow significantly by 2033.
  • Regional Market: North America is a key region for this market, with a projected CAGR of 7.6% from 2024 to 2033.
  • Pricing: Cetirizine is available as an OTC medication, making it affordable, with prices influenced by competition from generic and brand-name products.
  • Demand: Increasing instances of allergies drive the demand for cetirizine, which may stabilize or slightly increase prices.

FAQs

What is the primary use of cetirizine?

Cetirizine is primarily used to treat symptoms of allergies such as seasonal and perennial allergic rhinitis and chronic idiopathic urticaria.

How is the global allergy diagnostics and therapeutics market expected to grow?

The global allergy diagnostics and therapeutics market is expected to grow from $36.22 billion in 2024 to around $66.60 billion by 2033, at a CAGR of 7%.

What is the projected growth rate for the antihistamines segment within this market?

The antihistamines segment, which includes cetirizine, is expected to grow at a CAGR of 19% from 2024 to 2033.

Why is cetirizine preferred over first-generation antihistamines?

Cetirizine is preferred because it is a second-generation antihistamine that selectively inhibits the H1 receptor without causing sedating effects, unlike first-generation antihistamines.

How does the availability of generic versions affect the pricing of cetirizine?

The availability of generic versions of cetirizine keeps prices competitive and generally more affordable compared to brand-name versions.

What are the key factors influencing the price projections for cetirizine?

Key factors include increasing demand due to rising allergy prevalence, competitive market dynamics, and economic factors such as production costs and regulatory changes.

Sources

  1. DrugBank Online: Cetirizine: Uses, Interactions, Mechanism of Action.
  2. Wikipedia: Allergy.
  3. Biospace: Allergy Diagnostics and Therapeutics Market Size is Expanding.
  4. Department of Vermont Health Access: Over-the-Counter (OTC) Drugs Report.
  5. Prescriptions Plus Compounding: HM ALL DAY ALLR CET SF BBG 4Z.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.